SLAMF7 and hepatocellular carcinoma: We found that TM4SF5 expressed in hepatocytes or NK92 cells reduced NK cell cytotoxicity in vitro and in animal HCC models by binding to the stimulatory NK cell ligand and receptor SLAMF7, resulting in intracellular trafficking of SLAMF7 toward lysosomes for degradation.